Impact of Hemodilution on Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia

被引:0
|
作者
Tettero, Jesse [1 ,2 ]
Heidinga, Maaike [1 ]
Mocking, Tim [1 ]
Kelder, Angele [1 ]
Scholten, Willemijn [1 ]
Snel, Alexander [1 ]
Ngai, Lok Lam [1 ]
Bachas, Costa [1 ]
van de Loosdrecht, Arjan [1 ]
Ossenkoppele, Gert [1 ]
de Leeuw, David [1 ]
Janssen, Jeroen [3 ]
Cloos, Jacqueline [1 ]
机构
[1] Amsterdam UMC, Amsterdam, Netherlands
[2] Virginia Tech, FBRI Canc Res Ctr, Washington, DC USA
[3] Radboudumc, Nijmegen, Netherlands
关键词
AML; acute myeloid leukemia; hemodilution; measurable residual disease; MRD;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AML-348
引用
收藏
页码:S307 / S308
页数:2
相关论文
共 50 条
  • [11] Measurable Residual Disease in High-Risk Acute Myeloid Leukemia
    Cluzeau, Thomas
    Lemoli, Roberto M.
    McCloskey, James
    Cooper, Todd
    CANCERS, 2022, 14 (05)
  • [12] A 19-color single-tube full spectrum flow cytometry assay for the detection of measurable residual disease in acute myeloid leukemia
    Fokken, Hendrik
    Waclawski, Julian
    Kattre, Nadine
    Kloos, Arnold
    Mueller, Sebastian
    Ettinger, Max
    Kacprowski, Tim
    Heuser, Michael
    Maetzig, Tobias
    Schwarzer, Adrian
    CYTOMETRY PART A, 2024, 105 (03) : 181 - 195
  • [13] Measurable residual disease detected by flow cytometry independently predicts prognoses of NPM1-mutated acute myeloid leukemia
    Zhang, Yun-Wei
    Su, Long
    Tan, Ye-Hui
    Lin, Hai
    Liu, Xiao-Liang
    Liu, Qiu-Ju
    Sun, Jing-Nan
    Zhang, Ming
    Du, Ya-Zhe
    Song, Fei
    Han, Wei
    Gao, Su-Jun
    ANNALS OF HEMATOLOGY, 2023, 102 (02) : 337 - 347
  • [14] Flow cytometry in acute myeloid leukemia and detection of minimal residual disease
    Cai, Qihui
    Lan, Haiqiang
    Yi, Deng
    Xian, Bojun
    Zidan, Luo
    Li, Jianqiao
    Liao, Zhaohong
    CLINICA CHIMICA ACTA, 2025, 564
  • [15] Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia
    Gaut, Daria
    Oliai, Caspian
    Boiarsky, Jonathan
    Zhang, Shiliang
    Salhotra, Amandeep
    Azenkot, Tali
    Kennedy, Vanessa E.
    Khanna, Vishesh
    Olmedo Gutierrez, Karla
    Shukla, Navika
    Moskoff, Benjamin
    Park, Gabriel
    Afkhami, Michelle
    Patel, Anand
    Jeyakumar, Deepa
    Mannis, Gabriel
    Logan, Aaron C.
    Jonas, Brian A.
    Schiller, Gary
    LEUKEMIA & LYMPHOMA, 2024, 65 (01) : 69 - 77
  • [16] Measurable Residual Disease Assessment by Flow Cytometry in T-Cell Acute Lymphoblastic Leukemia
    Gajendra, Smeeta
    Gupta, Ritu
    Gupta, Sanjeev Kumar
    Gupta, Leena
    Rai, Sandeep
    Singh, Saroj
    Prajapati, Vijay Kumar
    Bakhshi, Sameer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S264 - S265
  • [17] Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going
    Dix, Caroline
    Lo, Tsun-Ho
    Clark, Georgina
    Abadir, Edward
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 14
  • [18] Validation of a 12-color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection
    Wang, Sa A.
    Jorgensen, Jeffrey L.
    Hu, Shimin
    Jia, Fuli
    Li, Shaoying
    Loghavi, Sanam
    Ok, Chi Young
    Thakral, Beenu
    Xu, Jie
    Medeiros, L. Jeffrey
    Wang, Wei
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (05) : 356 - 366
  • [19] Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia
    Vial, Jean Philippe
    Lechevalier, Nicolas
    Lacombe, Francis
    Dumas, Pierre-Yves
    Bidet, Audrey
    Leguay, Thibaut
    Vergez, Francois
    Pigneux, Arnaud
    Bene, Marie C.
    CANCERS, 2021, 13 (04) : 1 - 13
  • [20] Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia
    Liu, Fu-Jia
    Cheng, Wen-Yan
    Lin, Xiao-Jing
    Wang, Shi-Yang
    Jiang, Tian-Yi
    Ma, Ting-Ting
    Zhu, Yong-Mei
    Shen, Yang
    FRONTIERS IN ONCOLOGY, 2021, 11